Eleusis SPAC

eleusis Major Depressive Disorder (MDD) is the Silent Epidemic of the 21st Century Adults in the US with depression symptoms prior to the pandemic¹ 50M+ $113B $21B+ Antidepressant total addressable market expected by 2025³ $7B Driving massive direct health care expenditures² Estimated psychedelic care delivery total addressable US market4 Source: 1) Millions to gain access to Psychedelic Psychotherapy in bid to fight pandemic induced depression and anxiety. Yahoo Finance (June 17, 2021) (citing Anxiety and Depression Household Pulse Survey. CDC National Center for Health Statistics (accessed July 3, 2021); 2) Greenberg, P.E., et al. (2021) The Economic Burden of Adults With Major Depressive Disorder in the United States (2010 and 2018) Pharmaco Economics 39, 653-665 (number from 2018 and represents the aggregate of pharmaceutical and medical services); 3) Global Antidepressants Market Report 2021: COVID-19 Causes a Surge in Demand for Antidepressant Drugs as Mental Health Problems Rise - ResearchAnd Markets.com, Business Wire, April 26, 2021; 4) Partheniou, A. (2021) Psychedelics - A possible disrupter to legacy treatments, Stifel Nicholaus Canada Inc, 01/14/2021 (estimate based in part on data from existing ketamine clinics). 9

View entire presentation